Why We Didn't Patent Our Core Technology — And What That Means for You

If you spend any time researching a clean-tech company before you back it, you eventually check for patents. Search for ours and you won't find one on the C2C process itself. That's not an oversight, and I'd rather explain the decision than let you wonder about it.

A patent is a trade. You get twenty years of legal exclusivity, and in exchange the entire process gets published for the world to read, line by line. Anyone with the expertise — a competitor, a copycat, a country with less interest in respecting foreign IP — gets a blueprint. They don't get to sell it under our name, but they get to see exactly how it works and start building around it, or worse, finding the one input they'd need to replicate it without infringing the letter of the patent.

We made a different call: protect the C2C process as a trade secret instead. The same logic Coca-Cola uses on its formula, or KFC on its blend. Nobody outside the company knows the exact recipe, so nobody can copy it, full stop — not "copy it legally," copy it at all.

Here's how that actually gets enforced, because a trade secret is only as strong as the discipline around it. Every commercial agreement we sign carries a hard refusal on know-how disclosure — the process itself is never handed over, licensed, or explained in a way that could be reverse-engineered from the paperwork. Liability is capped at full contract value as a floor, not a ceiling, so there's real financial exposure if that discipline is ever broken. And on the sales side, we hold to a 90-day termination notice, which gives us room to act if a relationship starts looking like it's drifting toward a disclosure risk rather than a customer relationship.

What this means for you as someone evaluating the company: the protection isn't a filing that sits in a government database with an expiration date. It's a standing set of contract terms enforced on every single deal, indefinitely, with real money behind it if it's violated. Less visible than a patent number you can look up, but arguably harder to work around — because there's nothing published to work around in the first place.

Questions about how this affects a specific deal structure — reach out at [email protected], or follow along at x.com/NexusBioFuel